0
0.5
1
1.5
2+
Mortality
33%
Improvement
Relative Risk
Remdesivir Mustafa et al. LATE TREATMENT
Is late treatment with remdesivir beneficial for COVID-19?
Retrospective 444 patients in Pakistan
Lower mortality with remdesivir (not stat. sig., p=0.21)
c19early.org
Mustafa et al., Exploratory Research i.., Dec 2021
Favors remdesivir
Favors control